Prostate Cancer - Results from #21680

Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions - Abstract December 11, 2013

Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: Implications for focal salvage brachytherapy - Abstract December 11, 2013

The prostate cancer risk stratification (ProCaRS) project: Recursive partitioning risk stratification analysis - Abstract December 11, 2013

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity - Abstract December 11, 2013

High dose rate brachytherapy boost for prostate cancer: A systematic review - Abstract December 11, 2013

SUO 2013 - Abstract and Poster: Impact of prior docetaxel on sipuleucel-T product parameters in PROCEED patients December 10, 2013

Economic evaluation of sipuleucel-T immunotherapy in castration-resistant prostate cancer - Abstract December 10, 2013

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer - Abstract December 10, 2013

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening - Abstract December 10, 2013

The impact of technology diffusion on treatment for prostate cancer - Abstract December 9, 2013

Comorbidity and survival of Danish prostate cancer patients from 2000-2011: A population-based cohort study - Abstract December 9, 2013

Peripheral zone prostate-specific antigen density: An effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors - Abstract December 9, 2013

Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy - Abstract December 9, 2013

Does HistoScanning(TM) play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies - Abstract December 9, 2013

Models of care and NCCN Guideline adherence in very-low-risk prostate cancer - Abstract December 9, 2013

Immunotherapy and immune evasion in prostate cancer - Abstract December 7, 2013

Metastatic castration-resistant prostate cancer: Changing landscape with cabazitaxel - Abstract December 7, 2013

Prospective multicenter study of bone scintigraphy in consecutive patients with newly diagnosed prostate cancer - Abstract December 7, 2013

Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: A prospective multicenter cohort study - Abstract December 7, 2013

High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: Outcomes after 5-year follow-up - Abstract December 7, 2013

Page 1085 of 1437